Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022GlobeNewsWire • 04/13/22
Zymergen, Inc. (ZY) CEO Jay Flatley on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/23/22
Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 03/22/22
Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022GlobeNewsWire • 03/16/22
Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further TestingGlobeNewsWire • 03/07/22
Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare ConferenceGlobeNewsWire • 01/11/22
Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World's Largest Metagenomics Databases and Proprietary Synthetic Biology PlatformGlobeNewsWire • 01/10/22
ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Zymergen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 12/04/21
The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behalf of InvestorsBusiness Wire • 11/11/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Zymergen Inc. (ZY) on Behalf of InvestorsBusiness Wire • 11/10/21
Zymergen's (ZY) CEO Jay Flatley on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/03/21
Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/03/21
The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPOForbes • 10/13/21
ZY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2021 in the Class Action Filed on Behalf of Zymergen Inc. Limited ShareholdersNewsfile Corp • 10/04/21
Last Few Hours for Shareholders to Actively Participate in Zymergen, Inc. (ZY) Class Action: Bronstein, Gewirtz & Grossman, LLCNewsfile Corp • 10/04/21